Order Article Reprints

Tovar R, de Ceglia M, Ubaldi M, Rodríguez-Pozo M, Soverchia L, Cifani C, Rojo G, Gavito A, Hernandez-Folgado L, Jagerovic N, et al. Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity. Nutrients. 2023; 15(20):4448. https://doi.org/10.3390/nu15204448

Tovar, Rubén, Marialuisa de Ceglia, Massimo Ubaldi, Miguel Rodríguez-Pozo, Laura Soverchia, Carlo Cifani, Gema Rojo, Ana Gavito, Laura Hernandez-Folgado, Nadine Jagerovic, and et al. 2023. "Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity" Nutrients 15, no. 20: 4448. https://doi.org/10.3390/nu15204448

Tovar, R., de Ceglia, M., Ubaldi, M., Rodríguez-Pozo, M., Soverchia, L., Cifani, C., Rojo, G., Gavito, A., Hernandez-Folgado, L., Jagerovic, N., Ciccocioppo, R., Baixeras, E., Rodríguez de Fonseca, F., & Decara, J. (2023). Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity. Nutrients, 15(20), 4448. https://doi.org/10.3390/nu15204448